E.U. regulators have approved Procter & Gamble's (PG +0.2%) acquisition of Teva's (TEVA...

E.U. regulators have approved Procter & Gamble's (PG +0.2%) acquisition of Teva's (TEVA +0.1%) over-the-counter business, saying it doesn't raise any competitive concerns. The agency had looked closely at the impact on markets for topical anti-rheumatics, analgesics and expectorants - particularly in the Baltic countries - but found no anti-trust risks.

From other sites
Comments (4)
  • doc47
    , contributor
    Comments (1736) | Send Message
    How much money is involved here?
    12 Nov 2012, 01:26 PM Reply Like
  • Jorge_Soriano
    , contributor
    Comments (269) | Send Message
    What does this mean if you own TEVA shares?
    12 Nov 2012, 02:51 PM Reply Like
  • pybusc89@aol.com
    , contributor
    Comments (7) | Send Message
    I hold both Prcoctor and Gamble and Teva. What does this mean for me?
    12 Nov 2012, 02:54 PM Reply Like
  • Dividend Garden
    , contributor
    Comments (484) | Send Message
    Teva's market cap is $35 billion. If PG is aquiring them, they are probably paying a premium. We'll see...
    12 Nov 2012, 02:56 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs